Incidence and preventability of adverse drug events among older persons in the ambulatory setting.

By J. Gurwitz, T. Field, L. Harrold, J. Rothschild, Kristin Debellis, A. Seger, Cynthia A Cadoret, L. Fish, Lawrence D. Garber, M. Kelleher and 1 more. Journal of the American Medical Association (JAMA), 2003

1,780 citations recorded by the source corpus.

Subfields: Emergency Medical Services, Geriatrics and Gerontology, Toxicology

View Paper: https://www.semanticscholar.org/paper/f936b33d3f784a1cb62d7c9debd759fb9aa1d01c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Geriatrics and Gerontology

1. L. Fried

Citations in the corpus

• Clinical consequences of polypharmacy in elderly (2014, background): “Drug--drug interactions are a frequent cause of preventable ADEs and medication-related hospitalizations [18,22].”
• Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review (2017, methodology): “Gurwitz et al. [23] performed free-text searches based on systems developed by Honigman et al. [21, 22] to identify preventable ADEs among older patients in an ambulatory care setting.”
• National surveillance of emergency department visits for outpatient adverse drug events. (2006, background): “Other studies of outpatient ADEs have measured a range of outcomes including patient self-reported symptoms,(34) potential ADEs,(3) 5 and assessments of severity.(31) Nevertheless, studies of single EDs(30) and studies of ADEs in a local Medicare population(36) have found similar types of adverse ef”
• Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United States (2008, background): “Older adults are the largest per capita consumers of prescription medications(1) and the most at risk for medication-related adverse events.(4) Implementation of the Medicare Part D Prescription Drug Benefit and efforts by Congress and the US Food and Drug Administration to enhance postmarketing sur”
• American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2012, neutral): “Estimates from past studies in ambulatory and longterm care settings found that 27% of adverse drug events (ADEs) in primary care and 42% of ADEs in long-term care were preventable, with most problems occurring at the ordering and monitoring stages of care.(1,2) In a study of the 2000/2001 Medical E”
• Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies (2008, background): “The addition or discontinuation of enzyme-inducing and inhibiting drugs may have a particularly important impact on older patients, because these patients are at a high risk of adverse events (Gurwitz et al., 2003).”
• Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). (2006, background): “- 11 Anticoagulants, primarily warfarin, cause 10% of drugrelated adverse events in Medicare outpatients.(12,13) Not only do these hemorrhages decrease the net benefit of anticoagulant therapy, but the fear of iatrogenic”
• Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. (2005, methodology): “When we developed a treatment plan for a hypothetical patient using a conservative regimen created in accordance with CPGs, she was treated with multiple medications with high complexity, with the attendant risks of medication errors, adverse drug events, drug interactions, and hospitalization.(4,58”
• Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults (2007, background): “Other studies of adverse drug events in older adults have also found that high percentages of adverse drug events are caused by these medication classes (9, 47, 48).”